Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NanoFlu/NVX CoV 2373 combination vaccine - Novavax

Next Previous
X
Search
Drug Profile

NanoFlu/NVX CoV 2373 combination vaccine - Novavax

Alternative Names: Combined NanoFlu/NVX-CoV2373 vaccine - Novavax; ICC vaccine; NanoFlu/NVX-CoV2373 combination vaccine - Novavax; qNIV/CoV2373; qNIV2/SARS-CoV-2 rS; Quadrivalent HA nanoparticle influenza and SARS-CoV-2 rS nanoparticle combination vaccine

Latest Information Update: 13 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novavax
  • Class COVID-19 vaccines; Influenza virus vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III COVID 2019 infections; Influenza virus infections

Most Recent Events

  • 10 Dec 2024 NanoFlu/NVX CoV 2373 combination vaccine is available for licensing as of 10 Dec 2024. https://global.novavax.com/connect-with-us
  • 10 Dec 2024 Phase-III clinical trials in COVID-2019 infections (In adults, In the elderly, Prevention) (IM)
  • 10 Dec 2024 Phase-III clinical trials in Influenza virus infections (In adults, In the elderly, Prevention) (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top